HI
SIOX

Hudock Inc’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Hudock Inc’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-179
Closed – – 810
2022
Q3 		$0 Hold
179
– – ﹤0.01% 850
2022
Q2 		$0 Hold
179
– – ﹤0.01% 832
2022
Q1 		$0 Hold
179
– – ﹤0.01% 830
2021
Q4 		$0 Hold
179
– – ﹤0.01% 908
2021
Q3 		$0 Hold
179
– – ﹤0.01% 914
2021
Q2 		$0 Hold
179
– – ﹤0.01% 884
2021
Q1 		$0 Hold
179
– – ﹤0.01% 859
2020
Q4 		$0 Buy
+179
New +$521 ﹤0.01% 820

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudock Inc's SIOX Position: Q4 2022 in Review

Hudock Inc sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2022, closing a stake of 179 shares.

Hudock Inc first reported a position in SIOX in Q4 2020 and held it in 8 quarters. The position peaked at $0 in Q3 2022. 37 funds tracked by Wall St. Rank hold SIOX as of Q4 2022.

  • Hudock Inc reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Hudock Inc sold 179 Sio Gene Therapies Inc. Common Stock shares in Q4 2022.
  • Hudock Inc first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Hudock Inc's Sio Gene Therapies Inc. Common Stock position peaked at $0 in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.